Research
Traumatology, Surgical Critical Care and Emergency Surgery

A randomized, double-blind, placebo-controlled, doseescalation study to assess the anti-inflammatory activity, efficacy, and safety of intravenous SB-681323 in subjects at risk for development of acute lung injury or ARDS

PI: Jason Christie, M.D.
Investigators: Pat Kim
Joy Steele, BSN (267) 971-0021
Recruiting at HUP

• ISS >16 to <70
• Major trauma, admitted to ICU
• Randomization with 24 hours of trauma, not admission